Author response for "A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes" Kenichi Furihata, Hanaka Mimura, Shweta Urva, Tomonori Oura, Kenji Ohwaki, Takeshi Imaokacrossref(2021)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要